Cerenovus Enterprise
Payments companies reported to CMS as associated with Cerenovus Enterprise. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cerenovus Enterprise, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cerenovus Enterprise
These are the largest totals companies reported as associated with Cerenovus Enterprise. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Brian Snelling | Boca Raton, FL | Neurological Surgery | $3,323.00 |
| Gary Duckwiler | Los Angeles, CA | Vascular & Interventional Radiology | $1,500.00 |
| Seung Jeong | Pittsburgh, PA | Neurological Surgery | $1,470.55 |
| Muhammad Khan | Fairfax, VA | Vascular Neurology | $1,356.79 |
| David Van Wyck | Pinehurst, NC | Neurology (Psychiatry & Neurology) | $1,347.89 |
| Rahul Shah | Shreveport, LA | Neurocritical Care | $1,184.58 |
| Catherine Peterson | Rolling Hills Estates, CA | Diagnostic Radiology | $1,082.73 |
| Mohamed Elshikh | Iowa City, IA | Neuroradiology | $1,080.14 |
| Jay Howington | Savannah, GA | Neurological Surgery | $979.56 |
| Eytan Raz | New York, NY | Neuroradiology | $834.73 |
Prescribed Cerenovus Enterprise?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.